sanofi pasteur — The vaccines business of sanofi-aventis Group
Learn
VaccinePlace.com -- Search.  Know more.
Explore Protect Learn

[BACK]

There are 3 types of paralytic polio:

Spinal polio

  • This is the most common form of paralytic polio, and it accounted for 79% of paralytic cases from 1969 through 19791,2
  • It can cause paralysis of the muscles in the arms and legs, as well as the muscles that control breathing1,2

Bulbar polio

  • This severe type of polio affects the cranial nerves that control seeing, hearing, smelling, tasting, and swallowing1,2
  • It can interfere with any of these functions, but is most likely to affect a person’s ability to breathe, speak, and swallow; it can be fatal without respiratory support1,2

Bulbospinal polio

  • This is a combination of two types of polio: bulbar and spinal paralytic polio1,2
  • It can cause paralysis of the arms and legs, and may also affect breathing, swallowing, and heart function1,2

Sources:
1. Centers for Disease Control and Prevention (CDC). Epidemiology and Prevention of Vaccine-Preventable Diseases: The Pink Book. 9th ed. Washington, DC: Public Health Foundation; 2006:97-110. 2. MayoClinic.com. Polio. Available at: http://www.mayoclinic.com/invoke.cfm?id=DS00572. Accessed March 21, 2005.

Indication
IPOL vaccine is given to infants (as young as 6 weeks of age), children, and adults to prevent polio caused by poliovirus types 1, 2, and 3.

Safety Information
Side effects to IPOL vaccine include injection site pain, swelling, and redness; fever, loss of appetite, fussiness, and drowsiness. Other side effects may occur. If you notice any other problems or symptoms following vaccination, please contact your health-care professional immediately. Vaccination with IPOL vaccine may not protect all individuals.

For more information about IPOL vaccine, talk to your health-care professional.

[BACK]

Provided as a service by Sanofi Pasteur Inc.
Copyright © 2010 Sanofi Pasteur Inc.
This page last updated: 11-Aug-2010